Refer children with clinical danger signs or hypoxemia for hospital care promptly.
Utilize community healthcare worker networks to implement point-of-care testing for biomarkers where feasible.
Address barriers to pulse oximetry use including probe availability, cost, and staff training.
Monitoring & Follow-up
Monitor vital signs dynamically recognizing their limitations in sensitivity and specificity for early sepsis detection.
Observe for progression to severe illness defined by death or need for organ support within 2 days of presentation.
Track clinical and biomarker parameters to guide ongoing referral decisions.
Risks
Delayed presentation and referral contribute to high mortality in community settings.
Reliance solely on clinical danger signs may miss children at risk due to suboptimal accuracy.
Barriers to pulse oximetry and biomarker testing limit their current utility in resource-limited settings.
Patient & Prescribing Data
3,405 febrile children aged 1−59 months recruited from community settings in South and Southeast Asia
39.4% had prior community care; 5.7% received parenteral treatment; 3.9% progressed to severe illness requiring organ support or resulting in death within 2 days
Clinical Best Practices
Combine simple clinical parameters with pulse oximetry and host biomarker testing to improve referral decision-making.
Train community healthcare workers in use of pulse oximetry and point-of-care biomarker tests.
Prioritize early identification and referral of children showing clinical danger signs or hypoxemia to reduce mortality.
Consider local context including access barriers and resource availability when implementing referral protocols.
